EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study

Lisa Chu iD, Alexander Abitbol

Diabetic Medicine · 2025

DOI: 10.1111/dme.70119 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Lisa Chu und 1 weiteren Autor:innen. Beteiligte Einrichtung: LMC Diabetes & Endocrinology, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring, Blood Glucose, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dexcom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study investigated the real‐world clinical outcomes of switching from intermittently scanned continuous glucose monitoring (isCGM) to real‐time CGM (rtCGM) in adults with type 1 diabetes (T1D) from a large Canadian speciality care population.

Methods

This retrospective observational study examined data from January 1, 2018, through July 31, 2023, in the Canadian LMC Diabetes Registry. The analysis measured 6–12‐month change in HbA1c in adults with T1D who switched from isCGM to rtCGM and compared changes to a propensity score‐matched isCGM cohort. Changes in number of hypoglycaemic events, CGM metrics, body weight, and total daily dose (TDD) of insulin were also evaluated at 6–12‐month follow‐up.

Results

The full T1D rtCGM switch cohort comprised of 136 adults (mean: age 43 years, diabetes duration 20.9 years, baseline HbA1c 67 mmol/mol [8.2%]). For the full cohort, HbA1c was significantly lower at follow‐up compared to baseline (∆‐7 mmol/mol [∆‐0.6%], p < 0.001). The propensity score‐matched subset ( n = 84) of these participants had a greater HbA1c reduction compared to the matched isCGM cohort ( n = 84; adjusted mean difference, 5 mmol/mol [0.5%]; p = 0.002). The matched rtCGM switch subset had significantly higher time in range 3.9–10.0 mmol/L and lower time above range >10.0 mmol/L, time below range

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Blood Glucose Self-MonitoringBlood GlucoseHypoglycemic AgentsGlycemic ControlHumansRetrospective StudiesAdultMaleFemaleCanadaGlycated HemoglobinMiddle AgedInsulinHypoglycemiaTreatment OutcomeContinuous Glucose Monitoring

Stichwörter der Autor:innen

CanadaHbA1ccontinuous blood glucose monitoringhypoglycaemiatype 1 diabetes

Substanzen

Blood GlucoseGlycated HemoglobinInsulinHypoglycemic Agentshemoglobin A1c protein, human

Autor:innen und Institutionen

  • LMC Diabetes & Endocrinology, Toronto, Ontario, Canada.

ORCID-Profile: Lisa Chu

Förderung

  • Dexcom

Zitieren

APA

Chu, L., & Abitbol, A. (2025). Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study. Diabetic Medicine. https://doi.org/10.1111/dme.70119

Vancouver

Chu L, Abitbol A. Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study. Diabetic Medicine. 2025. doi:10.1111/dme.70119

BibTeX
@article{Chu2025,
  author = {Chu, Lisa and Abitbol, Alexander},
  title = {Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study},
  journal = {Diabetic Medicine},
  year = {2025},
  doi = {10.1111/dme.70119}
}
Kostenlos starten →